基本信息
浏览量:7
职业迁徙
个人简介
He is focused on the care and research of patients with myeloid malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). He also participated in the K12 Calabresi Immuno-Oncology Training Program and currently participates as an investigator in several clinical trials aimed at improving the outcomes of patients with AML and MDS.
Dr. Shallis also maintains research interest in epidemiological, outcomes and effectiveness research as it pertains to the hematologic malignancies with a goal of identifying barriers to effective care and ultimately strategies to improve the outcomes of patients with these malignant diseases. Dr. Shallis conducts research with the Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center at Yale University.
Dr. Shallis has presented his research at multiple regional, national and international meetings and is a member of the National Comprehensive Cancer Network (NCCN) clinical guidelines for MDS panel. He is an author on more than 50 peer-reviewed publications and book chapters, most of which as first author and has served as an ad hoc reviewer for many journals including Leukemia, Blood Advances, Leukemia Research, Acta Haematologica, Hematology, Therapeutic Advances in Hematology, Expert Review of Hematology, BMC Hematology, eJHaem, Future Oncology and Expert Review of Anticancer Therapy among others.
Dr. Shallis also maintains research interest in epidemiological, outcomes and effectiveness research as it pertains to the hematologic malignancies with a goal of identifying barriers to effective care and ultimately strategies to improve the outcomes of patients with these malignant diseases. Dr. Shallis conducts research with the Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center at Yale University.
Dr. Shallis has presented his research at multiple regional, national and international meetings and is a member of the National Comprehensive Cancer Network (NCCN) clinical guidelines for MDS panel. He is an author on more than 50 peer-reviewed publications and book chapters, most of which as first author and has served as an ad hoc reviewer for many journals including Leukemia, Blood Advances, Leukemia Research, Acta Haematologica, Hematology, Therapeutic Advances in Hematology, Expert Review of Hematology, BMC Hematology, eJHaem, Future Oncology and Expert Review of Anticancer Therapy among others.
研究兴趣
论文共 149 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Talha Badar,Ahmad Nanaa,Ehab Atallah,Rory M. Shallis, Sacchi de Camargo Correia Guilherme,Aaron D. Goldberg,Antoine N. Saliba,Anand Patel, Jan P. Bewersdorf, Adam S. DuVall, Danielle Bradshaw,Yasmin Abaza,
Leukemiapp.1-7, (2024)
Jan Philipp Bewersdorf, Kishan K. Patel,Rory M. Shallis, Nikolai A. Podoltsev,Tariq Kewan, Jessica Stempel,Lourdes Mendez,Maximilian Stahl, Eytan M. Stein,Scott F. Huntington, George Goshua,Amer M. Zeidan
American journal of hematologyno. 4 (2024): 606-614
Annals of Hematologyno. 1 (2024): 105-116
Blood (2023): 3252
HemaSphereno. S3 (2023): e30347e2-e30347e2
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn